Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells

International Journal of Urology

Volumn 3, Issue 1, 1996, Pages 39-46

  Kimura, Go ^a,c   Kasuya, Junko ^a   Giannini, Stefano ^a   Honda, Yoko ^b   Mohan, Subburaman ^b   Kawachi, Mark H ^a   Akimoto, Masato ^c   Fujita Yamaguchi, Yoko ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cell growth; IGF I receptor monoclonal antibody; IGFBPs; IGFs; Prostate cancer cells

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029885705     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1996.tb00628.x     Document Type: Article

References (31)

1. Daughaday WH. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinol 1990;127:1-4.
2. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-320 (Editorial).
3. Humbel RE. Review: Insulin-like growth factors I and II. Eur J Biochem 1990;190:445-462.
4. Perdue JF, LeBon TR, Kato J, Hampton B, Fujita-Yamaguchi Y. Binding specificities and transducing function of the different molecular weight forms of insulin-like growth factor-II (IGF-II) on IGF-I receptors. Endocrinol 1991;129:3101-3108.
5. Roth RA, Kiess W. Insulin-like growth factor receptors: Recent developments and new methodologies. Growth Regulation 1994;41(suppl 1):31-38.
6. Rechler MM. Insulin-like growth factor binding proteins. Vitam Horm 1993;47:1-114.
7. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
8. Rappolee DA, Wang A, Mark D, Werb Z. Novel method for studying mRNA phenotypes in single or small number of cells. J Cell Biochem 1989;39:1-11.
9. Daughaday WH, Rowein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989;10:68-91.
10. Gloudemans T, Pospiech I, Van Der Ven LTM, Lips CJM, Schneid H, Otter WD, Sussenbach JS. Expression and CpG methylation of insulin-like growth factor II gene in human smooth muscle tumors. Cancer Res 1992;52:6516-6521.
11. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983;132:6-13.
12. Thomas PS. Hybridization of denatured RNA transferred in dotted nitrocellulose paper. Methods Enzymol 1983;100:255-266.
13. Mohan S, Jennings JC, Linkhard TA, Baylink DJ. Primary structure of human skeletal growth factor: Homology with human insulin-like growth factor II. Biochem Biophys Acta 1988;966:44-55.
14. Mohan S, Baylink DJ. Evidence that the inhibition of TE85 human bone cell proliferation by agents which stimulates cAMP production may in part be mediated by changes in the IGF-II regulatory system. Growth Regul 1991;1:110-118.
15. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986; 154:138-143.
16. Giannini S, Mohan S, Kasuya J, Galli G, Rotella CM, LeBon TR, Fujita-Yamaguchi Y. Characterization of insulin-like growth factor-binding proteins produced by cultured fibroblasts from patients with noninsulin-dependent diabetes mellitus, insulin-dependent diabetes mellitus, or obesity. J Clin Endocrinol Metab 1994;79:1824-1830.
17. Mohan S, Dony C, Lang K, Chevalley T, Linkhart T, Libanati C, Baylink DJ. Glucocorticoid regulation of circulating human insulin-like growth factor binding protein-5 (IGFBP-5) measured by RIA. Program and Abstracts, #399, 76th Annual Meeting of the Endocrine Society, Anaheim, CA, June 15-18, 1994.
18. Mohan S, Strong DD, Lempert UG, Tremollieres F, Wergedal JE, Baylink DJ. Studies on regulation of IGFBP-3 and IGFBP-4 production in human bone cells. Acta Endocrinologica 1992;127:555-564.
19. La Tour D, Mohan S, Linkhart A, Baylink DJ, Strong DD. Inhibitory IGFBP and cloning, complete sequence, and physiological regulation. Mol Endocrinol 1990;4:1806-1814.
20. Shimasaki S, Shimonaka M, Zhang H-P, Ling N. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 1991;66:19646-19653.
21. Shimasaki S, Gao L, Shimonaka M, Ling N. Isolation and molecular cloning of insulin-like growth factor-binding protein-6. Mol Endocrinol 1991;5:938-948.
22. Xiong L, Kasuya J, Li SL, Kato J, Fujita-Yamaguchi Y. Growth-stimulatory monoclonal antibodies against human insulin-like growth factor I receptor. Proc Natl Acad Sxi USA 1992;89:5356-5360.
23. Li SL, Kato J, Paz IB, Kasuya J, Fujita-Yamaguchi Y. Two new monoclonal antibodies against the a subunit of the human insulin-like growth factor-I receptor. Biochem Biophys Res Commun 1993;196:92-98.
24. Shimasaki S, Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Progress in Growth Factor Res 1991;243:243-266.
25. Pietrzkowski Z, Mulholland G, Gomella L, Jameson BA, Wernicke D, Baserga R. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor I. Cancer Res 1993;53:1102-1106.
26. Blum WF, Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regul 1994;4(suppl 1):11-19.
27. Sakano K, Enjoh T, Numata F, Fujiwara H, Marumoto Y, Higashihashi N, Sato Y, Perdue JF, Fujita-Yamaguchi Y. The design, expression, and characterization of human insulin-like growth factor II mutants specific for either the IGF-II cation-independent mannose 6-phosphate receptor or IGF-I receptor. J Biol Chem 1991;266: 20626-20635.
28. Kanety H, Madjar Y, Dagan Y, Levi J, Papa MZ, Pariente C, Goldwasser B, Karasik A. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: Correlation with serum prostate-specific antigen. J Clin Endocrinol Metab 1993;77:229-233.
29. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 1992;75:1046-1053.
30. Perkel VS, Mohan S, Baylink DJ, Linkhart TA. An inhibitory insulin-like growth factor binding protein (IN-IGFBP) from human prostatic cell conditioned medium reveals N-terminal sequence identity with bone derived IN-IGFBP. J Clin Endocrinol Metab 1990;71:533-535.
31. Kaicer EK, Blat C, Harel L. IGF-I and IGF-binding proteins: Stimulatory and inhibitory factors secreted by human prostatic adenocarcinoma cells. Growth Factors 1991;4:231-237.